Holen Sie sich die Stockscreener-App
37.87
1.99%
0.74
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
15.96%
73.17
|
63.10 | 58.69 | 44.12 | 38.18 |
| Operating Income/Loss |
15.96%
-73.17
|
-63.10 | -58.69 | -44.12 | -38.18 |
| Income/Loss From Continuing Operations Before Tax |
19.49%
-66.02
|
-55.26 | -49.02 | -33.82 | -32.09 |
| Income Tax Expense/Benefit |
13.25%
0.072
|
0.083 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
19.44%
-66.10
|
-55.34 | -49.02 | -33.82 | -32.09 |
|
Net Income/Loss
|
19.44%
-66.10
|
-55.34 | -49.02 | -33.82 | -32.09 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.40%
58.43
|
58.20 | 56.80 | 56.52 | 50.19 |
| Diluted Average Shares |
0.40%
58.43
|
58.20 | 56.80 | 56.52 | 50.19 |
| Basic Earnings Per Share |
18.95%
-1.13
|
-0.95 | -0.86 | -0.60 | -0.64 |
| Diluted Earnings Per Share |
18.95%
-1.13
|
-0.95 | -0.86 | -0.60 | -0.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):